NKILT Therapeutics, Inc. Information
Contact top employees from
NKILT Therapeutics, Inc.
Summary
NKILT Therapeutics is a preclinical cell therapy biotech developing a novel off-the-shelf approach with a proprietary and first-in-class engineered CIR™NK cells that targets HLA-G, expressed in over 5...Show more
Industries
Biotechnology
Headquarters Location
Employees Size
1-10 employees
Specialties
Cell Therapy, NK Cells, Immuno-Oncology, Biotechnology, Cancer Research, Oncology, Hematology, Leukemia, Solid Tumors, HLA-G, Immune Cell Engineering
Founded
2021
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at NKILT Therapeutics, Inc. shows a diverse range of experience levels:
17% have been with the company for less than 1 year33% for 1–2 years50% for 3–4 yearsEx-employees positions
In Company
In New Company
Contact top employees from
NKILT Therapeutics, Inc.
Henri Bayle
Chief Scientific Officer and Chief Development Officer
Joseph Senesac
Acting Chief Technology Officer
MyLinh Duong
Consultant Scientist
Daman Kaur
Acting Chief Financial Officer, Controller, Chief of Staff
Jihyun Park
Senior Research Scientist (contract)
